Nuzolvence For Suspension
Product Images NDC 68547-915

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Nuzolvence (NDC 68547-915). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by La Jolla Pharmaceutical Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Chemical Structure (Nuzolvence 01)

Chemical Structure (Nuzolvence 01)
FDA Label Image

Figure (Nuzolvence 02)

Figure (Nuzolvence 02)
FDA Label Image

Figure (Nuzolvence 03)

Figure (Nuzolvence 03)
FDA Label Image

Figure (Nuzolvence 04)

Figure (Nuzolvence 04)
FDA Label Image

Figure (Nuzolvence 05)

Figure (Nuzolvence 05)
FDA Label Image

Figure (Nuzolvence 06)

Figure (Nuzolvence 06)
FDA Label Image

Figure (Nuzolvence 07)

Figure (Nuzolvence 07)
FDA Label Image

Figure (Nuzolvence 08)

Figure (Nuzolvence 08)
FDA Label Image

Figure (Nuzolvence 09)

Figure (Nuzolvence 09)
FDA Label Image

Figure (Nuzolvence 10)

Figure (Nuzolvence 10)
FDA Label Image

Figure (Nuzolvence 11)

Figure (Nuzolvence 11)
FDA Label Image

Figure (Nuzolvence 12)

Figure (Nuzolvence 12)
FDA Label Image

Figure (Nuzolvence 13)

Figure (Nuzolvence 13)
FDA Label Image

Figure (Nuzolvence 14)

Figure (Nuzolvence 14)
This text seems to be a note about medication management. It indicates that the person should drink 2 out of 2 doses, and there is no medicine left over.*
FDA Label Image

Figure (Nuzolvence 15)

Figure (Nuzolvence 15)
FDA Label Image

Principal Display Panel (3 g Packet Carton)

Principal Display Panel (3 g Packet Carton)
This is a description of NUZOLVENCE, a medication in the form of an oral suspension containing zoliflodacin. The medication comes in a unit-dose kit that includes a mixing container with a lid, instructions for use, and a medication guide for each patient. The directions specify that the oral suspension must be consumed within 15 minutes after mixing with 60 mL of water. It is essential to store the medication at room temperature and not freeze it. For further information, refer to the enclosed full prescribing information. Keep NUZOLVENCE and other drugs out of reach of children and contact 1-800-651-3861 for any questions about the medication. Distributed by La Jolla Pharmaceutical Company in Waltham, MA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.